139 related articles for article (PubMed ID: 38049323)
1. [Expression characteristics and clinical significance of CD109 in de novo acute myeloid leukemia].
Wang LX; Chen Y; Dong ST; Ren FG; Zhang YF; Chang JM; Tan YH; Chen XH; Wang HW; Xu ZF
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):770-774. PubMed ID: 38049323
[No Abstract] [Full Text] [Related]
2. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.
Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S
Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190
[TBL] [Abstract][Full Text] [Related]
3. The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma.
Tsutsumi S; Momiyama K; Ichinoe M; Kato T; Mogi S; Miyamoto S; Murakumo Y; Yamashita T
Anticancer Res; 2022 Apr; 42(4):2061-2070. PubMed ID: 35347029
[TBL] [Abstract][Full Text] [Related]
4. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
[TBL] [Abstract][Full Text] [Related]
5. SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.
Zhang F; Lin H; Gu A; Li J; Liu L; Yu T; Cui Y; Deng W; Yan M; Li J; Yao M
J Proteomics; 2014 May; 102():125-36. PubMed ID: 24667143
[TBL] [Abstract][Full Text] [Related]
6. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
[TBL] [Abstract][Full Text] [Related]
7. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling.
Lee KY; Kuo TC; Chou CM; Hsu WJ; Lee WC; Dai JZ; Wu SM; Lin CW
Cells; 2020 Dec; 10(1):. PubMed ID: 33375719
[TBL] [Abstract][Full Text] [Related]
9. CD109 is a potential target for triple-negative breast cancer.
Tao J; Li H; Li Q; Yang Y
Tumour Biol; 2014 Dec; 35(12):12083-90. PubMed ID: 25149155
[TBL] [Abstract][Full Text] [Related]
10. Human platelet antigen genotyping and expression of CD109 (human platelet antigen 15) mRNA in various human cell types.
Hwang SM; Kim MJ; Chang HE; Hong YJ; Kim TS; Song EY; Park KU; Song J; Han KS
Biomed Res Int; 2013; 2013():946403. PubMed ID: 23509816
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of CD109 expression in myxofibrosarcoma.
Emori M; Tsukahara T; Murata K; Sugita S; Sonoda T; Kaya M; Soma T; Sasaki M; Nagoya S; Hasegawa T; Wada T; Sato N; Yamashita T
J Surg Oncol; 2015 Jun; 111(8):975-9. PubMed ID: 26031650
[TBL] [Abstract][Full Text] [Related]
12. High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
Emori M; Tsukahara T; Murase M; Kano M; Murata K; Takahashi A; Kubo T; Asanuma H; Yasuda K; Kochin V; Kaya M; Nagoya S; Nishio J; Iwasaki H; Sonoda T; Hasegawa T; Torigoe T; Wada T; Yamashita T; Sato N
PLoS One; 2013; 8(12):e84187. PubMed ID: 24376795
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma.
Ye BG; Sun HC; Zhu XD; Chai ZT; Zhang YY; Ao JY; Cai H; Ma DN; Wang CH; Qin CD; Gao DM; Tang ZY
Oncotarget; 2016 May; 7(20):29333-45. PubMed ID: 27121053
[TBL] [Abstract][Full Text] [Related]
14. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
[TBL] [Abstract][Full Text] [Related]
15. CD109 expression is increased in cutaneous squamous cell carcinoma.
Dong F; Wang Y; Li L; Wang Y; Liu X; Liu J
J Dermatol; 2014 Oct; 41(10):947-9. PubMed ID: 25271095
[No Abstract] [Full Text] [Related]
16. CD109 is expressed in epithelial cells of the juvenile thymus.
Dong F; Wang Y; Li L; Liu X; Yan S; Liu J
Histopathology; 2015 Jun; 66(7):1041-4. PubMed ID: 25257548
[No Abstract] [Full Text] [Related]
17. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
18. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
19. Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.
Hagiwara S; Sasaki E; Hasegawa Y; Suzuki H; Nishikawa D; Beppu S; Terada H; Sawabe M; Takahashi M; Hanai N
Cancer Med; 2021 Feb; 10(4):1335-1346. PubMed ID: 33565282
[TBL] [Abstract][Full Text] [Related]
20. CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.
Dong F; Lu C; Chen X; Guo Y; Liu J
Diagn Pathol; 2015 Aug; 10():137. PubMed ID: 26249215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]